Search the Newsreel

Excelerate Energy (EE) Is Up 5.0% After Q2 EPS Jumps On Asset Redeployment And Jamaica Platform

Russian Attacks Destroy ArcelorMittal in Kryvyi Rih and Kyiv Book Market

Russian forces conducted missile and drone strikes on August 16, targeting civilian and industrial infrastructure in Ukraine. In Kryvyi Rih, an attack on the ArcelorMittal plant killed two workers, injured 13, and partially halted production. Simultaneously, a large-scale fire destroyed sections of Kyiv's historic …

Two killed as Russia targets Kryvyi Rih with missiles and drones

A Russian missile and drone attack on Kryvyi Rih overnight on August 15-16 killed two people and injured 13, damaging two industrial facilities, including the ArcelorMittal steel plant. The attack forced a partial halt to production at the steel plant, which sustained damage to …

Russians launch missile attack on ArcelorMittal Kryvyi Rih plant, killing two

A Russian missile strike hit the ArcelorMittal Kryvyi Rih plant on the night of August 15-16, resulting in one death and 13 injuries among employees and contractors. The attack damaged key production facilities, forcing some operations to be suspended while rescue efforts and damage …

Russian missile strike on "ArcelorMittal Kryvyi Rih" — two killed, 13 injured

A Russian missile strike on the "ArcelorMittal Kryvyi Rih" enterprise has resulted in two deaths and 13 injuries among employees and contractor organizations. The attack also caused significant damage to the main production facilities, leading to a partial halt in operations. Rescue efforts are …

Enemy missile attack hits ArcelorMittal Kryvyi Rih plant overnight, killing and injuring people

A Russian missile attack on the ArcelorMittal Kryvyi Rih plant overnight resulted in one fatality and several injuries, causing partial halt of production and damage to key facilities. The body of a previously missing victim was recovered from the rubble, bringing the total reported …

Russian troops strike ArcelorMittal Kryvyi Rih: two dead, main production facilities damaged

A missile strike by Russian forces on ArcelorMittal Kryvyi Rih resulted in two deaths and injuries to 13 employees and contractors. The attack damaged key production facilities in the power generation and blast furnace sectors, leading to a partial halt in the plant's production …

Russia launched a missile strike on the ArcelorMittal steel mill in Kryvyi Rih: the body of a second victim was recovered from the rubble, and there are injured people

Russian forces conducted a missile strike on the ArcelorMittal steel mill in Kryvyi Rih, resulting in at least two fatalities and fourteen injuries. The attack damaged power generation and blast furnace facilities, leading to a partial suspension of production. This is not the first …

Russia attacked the largest metallurgical plant – ArcelorMittal Kryvyi Rih

Russia launched missile strikes on ArcelorMittal Kryvyi Rih, Ukraine's largest metallurgical plant, resulting in two deaths and thirteen injuries. Key production facilities were damaged, leading to a partial halt in operations. This attack is part of ongoing Russian aggression impacting Ukraine's economy, including its …

Hexcel (NYSE:HXL) Lowered to Buy Rating by Wall Street Zen

Wall Street Zen downgraded Hexcel (NYSE:HXL) from a "strong buy" to a "buy" rating, although the broader analyst consensus remains "hold" with an average price target of $107.18. Hexcel recently reported strong quarterly results, beating EPS estimates by $0.09 and showing an 8% year-over-year …

How Investors May Respond To Celcuity (CELC) Winning FDA Nod For Revtopik Amid Wider Quarterly Loss

Why AbCellera (ABCL) Is Up 64.2% After Menopause Trial Win, Equity Raise And Vertex Deal

AbCellera Biologics (ABCL) saw its stock rise by 64.2% following positive Phase 2 results for its menopause drug ABCL635, a US$200 million equity raise, and a new collaboration with Vertex Pharmaceuticals. These developments strengthen its clinical pipeline and funding base, with the Vertex deal …

GL4 Forecast — Price Target — Prediction for 2027

This article provides an outlook on Accelerant Holdings Class A (GL4) stock, including analyst price targets, historical performance, and financial data. Analysts have provided 1-year price forecasts, with a maximum estimate of 26.02 EUR and a minimum of 14.75 EUR. The company's past earnings …

Why Cellebrite DI (CLBT) Is Down 30.4% After Cutting 2026 Outlook And Announcing CEO Transition

Cellebrite DI (CLBT) shares dropped 30.4% after the company lowered its 2026 revenue outlook to US$555 million–US$561 million, announced a CEO transition, and faced delays in large government contracts. This news has intensified investor concerns regarding execution, disclosure, and the conversion of AI and …

AbCellera (ABCL) Soars 64% as Drug Candidate Holds Huge Market Opportunity

AbCellera (ABCL) saw its stock price jump by 64% last week, becoming the top-performing mid-cap stock in the US market, following strong phase 2 clinical trial results for its drug candidate ABCL635 for hot flashes in menopausal women. The drug successfully reduced hot flash …

The Bull Case For Celcuity (CELC) Could Change Following Revtopik’s FDA Approval And NCCN Category 1 Status

Celcuity Inc. (CELC) reported a wider Q2 net loss of US$78.86 million but secured FDA approval and NCCN Category 1 status for Revtopik, its breast cancer drug. This development significantly alters the company's investment narrative, shifting focus from gedatolisib's potential to Revtopik's commercialization and …

CELH Stock On Track For Best Day In A Year After Post-Earnings Selloff — What’s Driving The Rally?

Celanese (CE) Reports Mixed Second Quarter Results, Is It A Bargain?

MLCMF SEC Filings - MILLICOM INTERNATIONAL CELLULAR SA 10-K, 10-Q, 8-K Forms

This page provides a comprehensive resource for MILLICOM INTERNATIONAL CELLULAR SA (Ticker: MLCMF) SEC filings, including 10-K, 10-Q, 8-K forms, and insider trading reports. Each filing is accompanied by expert analysis from Rhea-AI, offering insights into its potential market impact, an AI-generated summary, sentiment …

Should You Buy Excelerate Energy, Inc. (NYSE:EE) For Its Upcoming Dividend?

Celsius’s Q2 Earnings Call: Our Top 5 Analyst Questions

Celsius's Q2 Earnings Call: Our Top 5 Analyst Questions Celsius' second quarter was marked by a negative market reaction, as both revenue and non-GAAP profit fell short of Wall Street expectations. Management attributed this underperformance to the timing and depth of SKU rationalization within …

Omnicell, Inc. $OMCL Shares Acquired by Empowered Funds LLC

Empowered Funds LLC significantly increased its stake in Omnicell, Inc. (NASDAQ:OMCL) by 4,229.9% in the first quarter, now owning 262,043 shares valued at $8.7 million. This comes as other institutional investors have also adjusted their positions in the healthcare technology company. Insider transactions show …

Vericel Corporation $VCEL Shares Purchased by Bank of America Corp DE

Bank of America Corp DE significantly increased its stake in Vericel Corporation (NASDAQ:VCEL) during the first quarter, purchasing an additional 180,761 shares to own a total of 1.10 million shares valued at $35.3 million. This investment follows a strong financial performance by Vericel, which …

Celcuity (NASDAQ:CELC) Stock Rating Lowered by Wall Street Zen

Wall Street Zen downgraded Celcuity (NASDAQ:CELC) from a "sell" to a "strong sell," despite a "Moderate Buy" consensus from other analysts with an average price target of $153.64. The company's shares opened at $92, below its 52-week high, and reported a larger-than-expected quarterly loss …

Vericel Corp Director Kevin McLaughlin Executes Stock Options and Sells Shares Under 10b5-1 Plan

Vericel Corp (NASDAQ:VCEL) Director Kevin F. McLaughlin exercised stock options for 7,000 shares at $13.05 per share and subsequently sold those shares at $44.53 per share on August 12, 2026. These transactions were carried out under a pre-established Rule 10b5-1 trading plan adopted in …

ImmuCell Corporation - Common Stock (ICCC) Stock Price, News, Quote & History

Investors Purchase Large Volume of Call Options on United Parcel Service (NYSE:UPS)

Can AbCellera Biologics (ABCL)’s Vertex Pharmaceuticals Incorporated (VRTX) Deal Turn its TCE Platform Into a Breakthrough?

On July 29, AbCellera Biologics Inc. (NASDAQ:ABCL) and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) announced a strategic collaboration to research, develop, and commercialize multispecific T-cell engagers (TCEs) for autoimmune diseases. Under the agreement, AbCellera will leverage its proprietary TCE platform to lead discovery, while Vertex will …

BioXcel Therapeutics (BTAI) files Form 3 for new director Susan E. Atkins

BioXcel Therapeutics, Inc. (BTAI) has filed a Form 3 to report the initial beneficial ownership for its new director, Susan E. Atkins. This filing indicates her position as a director but does not list any equity transactions or current holdings. The document also notes …

BioXcel Therapeutics (BTAI) director receives option grant for 17,000 shares

BioXcel Therapeutics director Susan E. Atkins was granted stock options for 17,000 shares of common stock on August 12, 2026, with an exercise price of $1.06 per share and an expiration date of August 12, 2036. The options will vest over three years, with …

Accelerant Holdings (ARX) Stock Profit Rebound Meets Trailing Loss Overhang

Cellebrite (CLBT) Stock Rebounds As ARR Grows But Outlook Cools

Accelerant Holdings Director Nancy Hasley Sells 20,489 Class A Shares Under 10b5-1 Plan

Nancy Hasley, a Director at Accelerant Holdings (NYSE: ARX), sold 20,489 Class A Common Shares on August 13, 2026, at a weighted average price of $19.5636 per share. This transaction was executed under a pre-established Rule 10b5-1 trading plan. Following the sale, Hasley's direct …